Trademark: 97028652
Word
AVIDITY ADVANTAGE
Status
Pending
Status Code
641
Status Date
Tuesday, January 30, 2024
Serial Number
97028652
Mark Type
4000
Filing Date
Wednesday, September 15, 2021

Trademark Owner History

Classifications
9 Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers
5 Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical diagnostic use
1 Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes
10 Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers, none of the forgoing for use in the veterinary field
42 Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; providing online non-downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online non-downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes

Trademark Events
Jan 30, 2024
Notification Of Non-Final Action E-Mailed
Jan 30, 2024
Non-Final Action E-Mailed
Jan 30, 2024
Non-Final Action Written
Jan 2, 2024
Suspension Checked - To Attorney For Action
Apr 20, 2023
Report Completed Suspension Check Case Still Suspended
Oct 1, 2022
Notification Of Letter Of Suspension E-Mailed
Oct 1, 2022
Letter Of Suspension E-Mailed
Oct 1, 2022
Suspension Letter Written
Sep 9, 2022
Teas/Email Correspondence Entered
Sep 8, 2022
Correspondence Received In Law Office
Sep 8, 2022
Teas Response To Office Action Received
Mar 10, 2022
Notification Of Non-Final Action E-Mailed
Mar 10, 2022
Non-Final Action E-Mailed
Mar 10, 2022
Non-Final Action Written
Mar 1, 2022
Assigned To Examiner
Oct 21, 2021
New Application Office Supplied Data Entered
Sep 18, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24